BS12001 - Halogenated Butyl Rubber Stopper for Injection

Product Information:
Standards:
YBB00042005-2015
ISO/8536-2
USP (381)
EP (93.2.9)
JP (7.09)
Specifications:
32A (DIN)
32A (ISO)
31A
28B
28B1
28B-3
26B
26B1
26BF
26BF-2
25A-3
25B
24B
24BF
22B, etc.
 
Product Features:
BS6502: Main material: Brominated butyl rubber, gray, low hardness, suitable for ordinary infusion and therapeutic infusion.
BS6506: Main material: Brominated butyl rubber, gray, high hardness, suitable for ordinary infusion and therapeutic infusion.
BS650B: Main material: Brominated butyl rubber, gray, low hardness, suitable for ordinary infusion and therapeutic infusion.
BS650RF: Main material: Brominated butyl rubber, gray, high hardness, suitable for ordinary infusion.
BS5588: Main material: Chlorinated butyl rubber, gray, low hardness, suitable for ordinary infusion and therapeutic infusion.
 
Application Scenarios and Downstream Customers
Application Scenarios:
Hospitals and Clinics: For sealing injection vials used in various medical treatments and infusions.
Pharmaceutical Manufacturers: For packaging and sealing injectable medications.
Research Laboratories: For sealing vials in research and development of injectable drugs.
Veterinary Clinics: For sealing vials used in animal health injections.
Emergency Medical Services: For sealing vials used in emergency medication kits.
Downstream Customers:
Pharmaceutical Companies
Hospital Pharmacies
Research Institutions
Veterinary Pharmaceutical Manufacturers
Emergency Medical Providers
 
Business Opportunities and Market Potential Analysis
Business Opportunities in Latin America, Arab Countries, and Africa:
Market Demand:
Latin America: Growing pharmaceutical manufacturing sector and increasing healthcare infrastructure.
Arab Countries: Significant investments in healthcare and pharmaceutical industries, with a focus on modernizing medical facilities.
Africa: Expanding healthcare services and international support for improving medical infrastructure, leading to higher demand for reliable medical packaging solutions.
Market Potential:
Latin America: Government initiatives to improve healthcare access and quality, leading to increased demand for medical packaging products.
Arab Countries: Rapid development of healthcare facilities and a strong emphasis on adopting advanced medical technologies.
Africa: Growing investments in healthcare from local governments and international organizations, aiming to enhance medical care quality.
 
Resource and Condition Recommendations for Distributing This Product:
Resource Conditions:
Logistics Network: Reliable logistics capabilities to ensure proper storage and transportation of medical-grade rubber stoppers.
Marketing: Effective marketing strategies to educate pharmaceutical companies and healthcare providers on the benefits and applications of the product.
Technical Support: Provision of technical training and support to ensure correct usage and maximize customer satisfaction.
Recommended Conditions:
Infrastructure: Adequate warehousing and distribution facilities to handle medical packaging products.
Regulatory Compliance: Ensure that the product meets local regulatory requirements and obtain necessary certifications.
Partnerships: Establish relationships with local pharmaceutical companies, hospitals, and research institutions to facilitate market entry and adoption.
 
Primary Customer Targets:
Pharmaceutical Manufacturers: Companies producing injectable medications requiring reliable sealing solutions.
Hospitals and Clinics: Medical institutions needing high-quality stoppers for their injectable drug vials.
Research Laboratories: Institutions involved in the development and testing of new injectable drugs.
Veterinary Pharmaceutical Companies: Manufacturers of animal health injectable medications.
Emergency Medical Services: Providers of emergency medical kits that require secure vial sealing.
 
Summary
As distributors in Latin America, Arab countries, and Africa, there are significant market opportunities and potential in distributing the Halogenated Butyl Rubber Stopper for Injection (BS12001). With reliable logistics, effective marketing, and robust technical support conditions, and by establishing partnerships with local pharmaceutical companies, hospitals, and research institutions, this product can be successfully promoted and sold in these regions.